Since phosphorylation of the ERK-targeted domain (ETD) in HIF-1α by ERK1/2 is activated in human cancers [165] to allow HIF-1α accumulation into the nucleus, peptides that target this step have also been tested. The gene discussed is HIF1A; the disease is cancer.